A randomized phase II trial of nab‐paclitaxel and gemcitabine with tarextumab or placebo in patients with untreated metastatic pancreatic cancer.

Autor: Hu, Zishuo Ian1 (AUTHOR), Bendell, Johanna C.2 (AUTHOR), Bullock, Andrea3 (AUTHOR), LoConte, Noelle K.4 (AUTHOR), Hatoum, Hassan5 (AUTHOR), Ritch, Paul6 (AUTHOR), Hool, Hugo7 (AUTHOR), Leach, Joseph W.8 (AUTHOR), Sanchez, James9 (AUTHOR), Sohal, Davendra P. S.10 (AUTHOR), Strickler, John11 (AUTHOR), Patel, Ravindranath12 (AUTHOR), Wang‐Gillam, Andrea13 (AUTHOR), Firdaus, Irfan14 (AUTHOR), Yu, Kenneth H.1,15,16 (AUTHOR), Kapoun, Ann M.17 (AUTHOR), Holmgren, Eric17 (AUTHOR), Zhou, Lei17 (AUTHOR), Dupont, Jakob17 (AUTHOR), Picozzi, Vincent18 (AUTHOR)
Zdroj: Cancer Medicine. Sep2019, Vol. 8 Issue 11, p5148-5157. 10p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje